What is QTRX's health score?

Quanterix Corp (QTRX) has a TradeApes health score of 48 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is QTRX's estimated fair value?

Based on our 5-year discounted cash flow model, Quanterix Corp's estimated fair value is $7.79 per share, representing a 105.1% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is QTRX undervalued or overvalued?

Our model currently rates QTRX as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for QTRX... Refresh in a moment for the full analysis.

Quanterix Corp (QTRX)

Healthcare Undervalued low mixed

$3.8

Updated: 2026-06-04

TradeApes Score

Financial Strength

55 Mixed

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

40 Weak

Risk

80 Strong

Est. Fair Value $7.79

DCF Upside +105.1%

Sector Rank #751 of 6855

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Large FCF burn — cash consumption exceeds 10% of revenue

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.